|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. CA Cancer J Clin. 63:11–30. 2013.
|
|
2
|
Mayo SC and Pawlik TM: Current management
of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol.
3:131–144. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berri RN and Abdalla EK: Curable
metastatic colorectal cancer: recommended paradigms. Curr Oncol
Rep. 11:200–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartwell KA, Muir B, Reinhardt F,
Carpenter AE, Sgroi DC and Weinberg RA: The Spemann organizer gene,
Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA.
103:18969–18974. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mani SA, Yang J, Brooks M, et al:
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is
associated with aggressive basal-like breast cancers. Proc Natl
Acad Sci USA. 104:10069–10074. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Surguchov A: Molecular and cellular
biology of synucleins. Int Rev Cell Mol Biol. 270:225–317. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahmad M, Attoub S, Singh MN, Martin FL and
El-Agnaf OM: γ-Synuclein and the progression of cancer. FASEB J.
21:3419–3430. 2007.
|
|
9
|
Ji H, Liu YE, Jia T, et al: Identification
of a breast cancer-specific gene, BCSG1, by direct differential
cDNA sequencing. Cancer Res. 57:759–764. 1997.PubMed/NCBI
|
|
10
|
Guo J, Shou C, Meng L, et al: Neuronal
protein synuclein γ predicts poor clinical outcome in breast
cancer. Int J Cancer. 121:1296–1305. 2007.
|
|
11
|
Hibi T, Mori T, Fukuma M, et al:
Synuclein-γ is closely involved in perineural invasion and distant
metastasis in mouse models and is a novel prognostic factor in
pancreatic cancer. Clin Cancer Res. 15:2864–2871. 2009.
|
|
12
|
Dokun OY, Florl AR, Seifert HH, Wolff I
and Schulz WA: Relationship of SNCG, S100A4, S100A9 and LCN2 gene
expression and DNA methylation in bladder cancer. Int J Cancer.
123:2798–2807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu H, Liu W, Wu Y, et al: Loss of
epigenetic control of synuclein-γ gene as a molecular
indicator of metastasis in a wide range of human cancers. Cancer
Res. 65:7635–7643. 2005.PubMed/NCBI
|
|
14
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar
|
|
15
|
Fung KM, Rorke LB, Giasson B, Lee VM and
Trojanowski JQ: Expression of alpha-, beta-, and gamma-synuclein in
glial tumors and medulloblastomas. Acta Neuropathol. 106:167–175.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bruening W, Giasson BI, Klein-Szanto AJ,
Lee VM, Trojanowski JQ and Godwin AK: Synucleins are expressed in
the majority of breast and ovarian carcinomas and in preneoplastic
lesions of the ovary. Cancer. 88:2154–2163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye Q, Wang TF, Peng YF, et al: Expression
of α-, β- and γ-synuclein in colorectal cancer, and potential
clinical significance in progression of the disease. Oncol Rep.
23:429–436. 2010.
|
|
18
|
Ye Q, Zheng MH, Cai Q, et al: Aberrant
expression and demethylation of γ-synuclein in colorectal cancer,
correlated with progression of the disease. Cancer Sci.
99:1924–1932. 2008.
|
|
19
|
Jia T, Liu YE, Liu J and Shi YE:
Stimulation of breast cancer invasion and metastasis by synuclein
γ. Cancer Res. 59:742–747. 1999.PubMed/NCBI
|
|
20
|
Surgucheva IG, Sivak JM, Fini ME, Palazzo
RE and Surguchov AP: Effect of γ-synuclein overexpression on matrix
metalloproteinases in retinoblastoma Y79 cells. Arch Biochem
Biophys. 410:167–176. 2003.
|
|
21
|
Gupta A, Inaba S, Wong OK, Fang G and Liu
J: Breast cancer-specific gene 1 interacts with the mitotic
checkpoint kinase BubR1. Oncogene. 22:7593–7599. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inaba S, Li C, Shi YE, Song DQ, Jiang JD
and Liu J: Synuclein gamma inhibits the mitotic checkpoint function
and promotes chromosomal instability of breast cancer cells. Breast
Cancer Res Treat. 94:25–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan ZZ, Bruening W and Godwin AK:
Involvement of RHO GTPases and ERK in synuclein-γ enhanced cancer
cell motility. Int J Oncol. 29:1201–1205. 2006.PubMed/NCBI
|
|
24
|
Gennari L, Russo A and Rossetti C:
Colorectal cancer: what has changed in diagnosis and treatment over
the last 50 years? Tumori. 93:235–241. 2007.PubMed/NCBI
|
|
25
|
Samoha S and Arber N: Cyclooxygenase-2
inhibition prevents colorectal cancer: from the bench to the bed
side. Oncology. 69:33–37. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou CQ, Liu S, Xue LY, et al:
Down-regulation of γ-synuclein in human esophageal squamous cell
carcinoma. World J Gastroenterol. 9:1900–1903. 2003.
|
|
27
|
Pan ZZ, Bruening W, Giasson BI, Lee VM and
Godwin AK: γ-synuclein promotes cancer cell survival and inhibits
stress- and chemotherapy drug-induced apoptosis by modulating MAPK
pathways. J Biol Chem. 277:35050–35060. 2002.
|
|
28
|
Liu YE, Pu W, Jiang Y, Shi D, Dackour R
and Shi YE: Chaperoning of estrogen receptor and induction of
mammary gland proliferation by neuronal protein synuclein gamma.
Oncogene. 26:2115–2125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang Y, Liu YE, Goldberg ID and Shi YE:
γ-synuclein, a novel heat-shock protein-associated chaperone,
stimulates ligand-dependent estrogen receptor α signaling and
mammary tumorigenesis. Cancer Res. 64:4539–4546. 2004.
|
|
30
|
Gupta GP and Massague J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
32
|
Hu H, Sun L, Guo C, et al: Tumor
cell-microenvironment interaction models coupled with clinical
validation reveal CCL2 and SNCG as two predictors of colorectal
cancer hepatic metastasis. Clin Cancer Res. 15:5485–5493. 2009.
View Article : Google Scholar : PubMed/NCBI
|
